July 16 (UPI) --Doctors are regularly overlooking a common hormone-driven cause of high blood pressure, a new paper warns. As many as 30% of high blood pressure patients seen by heart specialists and ...
Mineralys' lorundrostat, a selective aldosterone synthase inhibitor, shows promise in treating resistant hypertension with fewer side effects compared to current MRAs. Upcoming catalysts include ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback